We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

206 hedge funds and large institutions have $5.22B invested in Legend Biotech in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 58 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

201% more call options, than puts

Call options by funds: $58.4M | Put options by funds: $19.4M

60% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 58

26% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 27

3% more funds holding

Funds holding: 200 → 206 (+6)

0.22% more ownership

Funds ownership: 26.05% → 26.27% (+0.22%)

10% less capital invested

Capital invested by funds: $5.78B → $5.22B (-$559M)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

Holders
206
Holders Change
+6
Holders Change %
+3%
% of All Funds
3%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.1%
New
34
Increased
93
Reduced
58
Closed
27
Calls
$58.4M
Puts
$19.4M
Net Calls
+$39M
Net Calls Change
+$40.4M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$70.6M
2
Morgan Stanley
Morgan Stanley
New York
+$62.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$61M
4
BlackRock
BlackRock
New York
+$40.9M
5
Millennium Management
Millennium Management
New York
+$35.3M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$197M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$69.3M
3
NIP
Nicholas Investment Partners
California
-$35.9M
4
PCH
Polar Capital Holdings
United Kingdom
-$31.8M
5
HA
HHLR Advisors
Cayman Islands
-$28.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
26
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$36.6M +$1.17M +18,525 +3%
BC
27
Boxer Capital
California
$36.1M – – –
Millennium Management
28
Millennium Management
New York
$35M +$35.3M +556,342 +2,156%
SPPAM
29
Summit Partners Public Asset Management
Massachusetts
$34.1M +$9.98M +157,474 +39%
B
30
Braidwell
Connecticut
$33.9M -$20.1M -316,964 -36%
ACP
31
Altitude Crest Partners
Connecticut
$32.6M +$34.3M +541,816 New
Goldman Sachs
32
Goldman Sachs
New York
$31.4M +$16.5M +260,899 +100%
Artisan Partners
33
Artisan Partners
Wisconsin
$31.2M -$2.75M -43,435 -8%
RSCM
34
Rock Springs Capital Management
Maryland
$29.6M +$2.17M +34,179 +7%
JP Morgan Chase
35
JP Morgan Chase
New York
$29.4M +$2.36M +37,301 +8%
FTM
36
First Turn Management
California
$28.6M +$30.2M +476,079 New
Canada Pension Plan Investment Board
37
Canada Pension Plan Investment Board
Ontario, Canada
$27.5M – – –
Geode Capital Management
38
Geode Capital Management
Massachusetts
$26.4M +$5.05M +79,673 +22%
CII
39
Capital International Inc
California
$26M -$1.83M -28,820 -6%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
40
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$25.1M +$21.5M +338,600 +431%
Franklin Resources
41
Franklin Resources
California
$23.2M +$507 +8 +0%
ITP
42
Iron Triangle Partners
Connecticut
$22.9M -$4.6M -72,629 -16%
Bank of America
43
Bank of America
North Carolina
$20.9M +$4.83M +76,225 +28%
BA
44
Bridgewater Associates
Connecticut
$19.9M -$1.39M -22,000 -6%
Legal & General Group
45
Legal & General Group
United Kingdom
$18.5M +$1.94M +30,615 +11%
UBS AM
46
UBS AM
Illinois
$18.1M +$2.41M +38,001 +14%
UBS Group
47
UBS Group
Switzerland
$18M -$148K -2,332 -0.8%
CS
48
Candriam SCA
Luxembourg
$14.5M +$634K +10,000 +4%
TD Asset Management
49
TD Asset Management
Ontario, Canada
$14.3M -$2.11M -33,344 -12%
DCM
50
Driehaus Capital Management
Illinois
$14.1M +$1.78M +28,103 +14%
1
2
3 4 5

LEGN Hedge Fund Activity: Q4 2023 in Review

206 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2023, worth a combined $5.22B — down 9.7% from $5.78B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new LEGN positions and 27 closed out — a net gain of 7 holders — while 93 added to existing stakes and 58 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $70.6M. The largest seller was Fidelity Investments, cutting an estimated $197M.

  • 206 institutional investors held Legend Biotech (LEGN) as of Q4 2023, up from 200 in Q3 2023.
  • Funds reported $5.22B of Legend Biotech stock for Q4 2023, down 9.7% quarter-over-quarter.
  • 34 funds opened new Legend Biotech positions in Q4 2023 and 27 closed out, a net change of +7 holders.
  • The largest Legend Biotech buyer in Q4 2023 was T. Rowe Price Associates, an estimated $70.6M added.
  • The largest Legend Biotech seller in Q4 2023 was Fidelity Investments, an estimated $197M sold.

Based on aggregated 13F filings for Q4 2023.